Change in the total number of shares and votes in Recipharm AB (publ)

In January 2015, the number of shares in Recipharm AB (publ) (“Recipharm”) has
increased by 2,114,999 shares of series B, corresponding to 2,114,999 votes. The
increase in the number of shares and votes results from conversion of
convertible bonds issue in connection with the acquisition of Corvette
Pharmaceutical Services Group, completed on 1 October 2015.
As of 30 January 2015, the total number of shares in Recipharm amounts to
42,803,874, divided into 12,685,716 shares of series A and 30,118,158 shares of
series B. The total number of votes in Recipharm as of 30 January 2015 amounts
to 156,975,318.

This information is published in accordance with Chapter 4, Section 9 of the
Swedish Financial Instruments Trading Act (SFS 1991:980).

For further information please visit www.recipharm.com or contact:
Thomas Eldered, CEO, thomas.eldered@recipharm.com, telephone: +46 8 602 52 10
Björn Westberg, CFO, bjorn.westberg@recipharm.com, telephone: +46 8 602 46 20

This information is published in accordance with the Swedish Securities Market
Act, the Swedish Financial Instruments Trading Act and/or the regulations of
NASDAQ Stockholm. This information was submitted for publication on 30 January
2015 at 08:30 am CET.

About Recipharm
Recipharm is a leading CDMO (Contract Development and Manufacturing
Organisation) in the pharmaceutical industry based in Sweden employing some
2,200 employees. Recipharm offers manufacturing services of pharmaceuticals in
various dosage forms, production of clinical trial material including API and
pharmaceutical product development. Recipharm manufactures more than 400
different products to customers ranging from Big Pharma through to smaller
research- and development companies. Recipharm’s turnover is approximately SEK
3.3 billion and the Company operates development and manufacturing facilities in
Sweden, France, the UK, Germany, Spain, Italy and Portugal and is headquartered
in Jordbro, Sweden. The Recipharm B-share (RECI B) is listed on NASDAQ
Stockholm.

For more information on Recipharm and our services, please visit
www.recipharm.com (http://file///C:/Users/Thomas/AppData/Local/Microsoft/Windows
/ 
Temporary%20Internet%20Files/Content.Outlook/FZHEQOEB/visit%20www.recipharm.com)
. 

Recipharm AB (publ)
Corporate identity number 556498-8425
Address Lagervägen 7, SE-136 50 Jordbro, Sweden, Telephone 46 8 602 52
00, Fax 46 8 81 87 03
www.recipharm.com